Advanced glycosylation end product-specific receptor antagonist
Product Description
Information
Azeliragon (TTP488, PF-04494700) is an orally bioavailable small molecule that inhibits thereceptor for advanced glycation endproducts (RAGE), which is an immunoglobulin-like cell surface receptor overexpressed in brain tissues of patients with AD.
Product Properties
ALogP
8.3
Associated Targets(Human)
AGERTchemAdvanced glycosylation end product-specific receptor (2 Activities)
1.Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J et al.. (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.. Nat Med, 9 (7):(907-13). [PMID:12808450]
2.Burstein AH, Grimes I, Galasko DR, Aisen PS, Sabbagh M, Mjalli AM. (2014) Effect of TTP488 in patients with mild to moderate Alzheimer's disease.. BMC Neurol, 14 (3):(12). [PMID:24423155]
3.Saito S, Ihara M. (2014) New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy.. Front Aging Neurosci, 6 (3):(290). [PMID:25368578]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.